Aemetis (AMTX) Registration Filing summary

Financial performance and metrics

• Revenues declined from $256.5 million in 2022 to $186.7 million in 2023, with a net loss of $46.4 million in 2023 compared to a net loss of $107.8 million in 2022.

• Gross profit for 2023 was $2.0 million, with an operating loss of $37.4 million and interest expense of $39.5 million.

• Total assets as of December 31, 2023, were $243.4 million, with a stockholders' deficit of $216.98 million.

• Net loss per share improved to $(1.22) in 2023 from $(3.12) in 2022.

Use of proceeds and capital allocation

• Net proceeds from the sale of securities are intended for general corporate purposes unless otherwise specified in a prospectus supplement.

Risk factors and disclosures

• Investing in the securities involves significant risks, including those detailed in the incorporated annual and quarterly reports.

• Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.